Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

When will a generic version of xiaflex be available?
Tenofovir generic patent?
Patent expiration date of guselkumab?
Dabrafenib patent expiration date novartis gsk composition matter?
Brenzavvy discontinuation?

Movantik 12.5 mg?

See the DrugPatentWatch profile for Movantik

Movantik (naldemedine) – 12.5 mg tablet

What it is A prescription‑only, peripherally acting μ‑opioid receptor antagonist (PAMORA) used to treat constipation that is caused by long‑term opioid use.
Approved indication Chronic constipation in adults who are taking opioids for pain relief. It does not treat constipation of other causes.
Typical dosing 12.5 mg once daily (the only approved strength). Take the tablet orally with or without food. The dose is usually started at 12.5 mg; if needed, the dose can be increased to 25 mg after 2–4 weeks if the benefit is inadequate.
How it works Naldemedine blocks opioid receptors in the gastrointestinal tract, which helps restore normal bowel motility without interfering with pain control.
Common side‑effects • Nausea
• Vomiting
• Abdominal pain or cramping
• Diarrhea (often the desired effect)
• Flatulence
Less common but more serious • Hypotension (especially in patients on other antihypertensives)
• Severe GI distress
• Allergic reactions (rash, itching, swelling)
Contraindications / cautions • Pregnancy (data limited; potential risks) – use only if clearly needed.
• Severe hepatic impairment (monitor liver enzymes).
• Use with caution in patients taking other strong opioid analgesics or opioids with poor absorption (e.g., methadone).
Drug interactions • P‑glycoprotein inhibitors (e.g., ketoconazole, ritonavir) can increase naldemedine levels.
• Other opioids: can potentiate opioid‑induced bowel changes; monitor closely.
• Laxatives: may be used concurrently for better bowel control.
Storage Keep at room temperature (≤25 °C / 77 °F), away from moisture and direct sunlight. Keep out of reach of children.
What to tell your provider • Any other GI medications (e.g., laxatives, stool softeners).
• History of liver disease or kidney disease.
• Current opioid regimen (dose, type, schedule).
Monitoring • Check bowel movements (frequency, form) and any abdominal symptoms.
• Periodic review of pain control and constipation to decide whether to continue, adjust dose, or discontinue.

Quick take‑home points

  1. Take exactly one tablet daily; do not double up to “catch up.”
  2. It does not relieve pain – it only helps the bowel.
  3. Keep your healthcare team informed about any new GI symptoms, especially severe abdominal pain or vomiting.
  4. Do not stop abruptly if you’re on a stable dose; your provider may want a taper plan.
  5. Report any allergic reactions or persistent nausea/vomiting to your prescriber.

Bottom line: Movantik 12.5 mg is a helpful option for adults who are on long‑term opioid therapy and develop constipation. It works locally in the gut, so it usually doesn’t compromise pain relief. Still, it’s a prescription drug that should be used under medical supervision, with regular monitoring for side effects and interactions. If you have specific concerns—like how it fits with your current meds or if it’s safe during pregnancy—talk to your doctor or pharmacist.



Other Questions About Movantik :

Movantik medication? Movantik 25 mg? Movantik pricing movantik availability? Movantik cost without insurance? Movantik generic availability 2026? Movantik uses? Movantik 25 mg cost?